top of page
Profile
Join date: Apr 17, 2024
Posts (8)
Oct 1, 2024 ∙ 2 min
One Step Closer to LAMA2-RD Clinical Trials: Modalis Therapeutics
Modalis Therapeutics program for LAMA2-RD gene therapy granted Rare Pediatric Disease Designation by FDA.
1180
0
Sep 24, 2024 ∙ 5 min
Research Update: LMNA
We are honored to support groundbreaking discoveries related to LMNA-CMD.
268
0
Aug 8, 2024 ∙ 3 min
Research Update: Dystroglycanopathy
We are honored to support groundbreaking discoveries related to Dystroglycanopathy.
189
0
Gustavo Dziewczapolski, Scientific Director
Writer
More actions
bottom of page